Related Experiment Video
Updated: Dec 10, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Birth Size as a Determinant of Cardiometabolic Risk Factors in Children
Henrikki Nordman1, Jarmo Jääskeläinen2, Raimo Voutilainen2
1Department of Pediatrics, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland, hnordman@student.uef.fi.
Insights
Children born small (SGA) or large (LGA) for gestational age face increased cardiometabolic disease risk. Early growth patterns and later weight gain significantly influence this risk, highlighting the need for weight management interventions.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Health
- Metabolic Syndrome Research
Background:
- Birth size, including small for gestational age (SGA) and large for gestational age (LGA), is linked to later cardiometabolic disease risk.
- While SGA's association with cardiovascular risk is established, LGA's impact remains debated.
- Early postnatal growth and subsequent weight gain are critical factors influencing adult cardiometabolic health.
Purpose of the Study:
- To explore the association between birth size (SGA and LGA) and cardiometabolic disease risk.
- To investigate the role of early growth patterns and later weight gain in mediating this association.
- To emphasize the importance of maintaining normal weight for reducing long-term cardiometabolic risk in SGA and LGA individuals.
Main Methods:
- The study reviews existing literature on birth size, early growth trajectories, and adult cardiometabolic outcomes.
- It analyzes the influence of catch-up (SGA) and catch-down (LGA) growth on health.
- Risk factors such as overweight, obesity, glucose metabolism, dyslipidemia, hypertension, and inflammation are considered.
Main Results:
- Both SGA and LGA birth sizes are associated with an increased risk of overweight and obesity, which often persists into adulthood.
- Early compensatory growth in SGA and catch-down growth in LGA may contribute to adverse health outcomes.
- Altered glucose metabolism, dyslipidemia, hypertension, and low-grade inflammation are linked to birth weight and are often related to overweight or adverse fat distribution.
Conclusions:
- Maintaining a normal weight throughout life is crucial for mitigating cardiometabolic risk in individuals born SGA or LGA.
- Effective interventions targeting weight management are needed for SGA and LGA children to reduce their long-term cardiometabolic risk.
- Further research should focus on developing and implementing these interventions.
Abstract:
The association between birth size and cardiometabolic disease risk may be U-shaped. Being born small for gestational age (SGA) has a definitive association with later cardiovascular risk, but the impact of being born large for gestational age (LGA) on cardiometabolic health is more controversial. In addition to birth size, early postnatal growth pattern and later weight gain affect cardiometabolic risk in adulthood. Most SGA-born children have catch-up and LGA-born children have catch-down growth during the first years of life. The extent of this early compensatory growth may contribute to the adverse health outcomes. Both SGA- and LGA-born children are at an increased risk for overweight and obesity. This may have a long-term impact on cardiometabolic health as overweight tends to track to adulthood. Other cardiometabolic risk factors, including alterations in glucose metabolism, dyslipidemia, hypertension, and low-grade inflammation are associated with birth weight. Many of these risk factors are related to overweight or adverse fat distribution. Since later cardiometabolic risk is often mediated by early growth pattern and later overweight in SGA and LGA children, it is important to focus on staying normal weight throughout life. Hence, effective interventions to reduce cardiometabolic risk in LGA and SGA children should be developed.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Obesity
Pharmacokinetics in Pediatric Patients: Drug Distribution
Coronary Artery Disease I: Introduction
Drug Dosing: Infants and Children
Nature and Nurture

